CO6341545A2 - Metodo para elaborar una microesfera de liberacion sostenida mediante un metodo de la evaporacion de solvente - Google Patents

Metodo para elaborar una microesfera de liberacion sostenida mediante un metodo de la evaporacion de solvente

Info

Publication number
CO6341545A2
CO6341545A2 CO11023782A CO11023782A CO6341545A2 CO 6341545 A2 CO6341545 A2 CO 6341545A2 CO 11023782 A CO11023782 A CO 11023782A CO 11023782 A CO11023782 A CO 11023782A CO 6341545 A2 CO6341545 A2 CO 6341545A2
Authority
CO
Colombia
Prior art keywords
release
microphase
developing
sustained
solvent evaporation
Prior art date
Application number
CO11023782A
Other languages
English (en)
Inventor
Nak Hyun Lim
Seyeon Kim
Hyung Joon Jung
Sun Geun Kim
Kyung Hoi Cha
Original Assignee
Dong Kook Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41722136&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO6341545(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dong Kook Pharm Co Ltd filed Critical Dong Kook Pharm Co Ltd
Publication of CO6341545A2 publication Critical patent/CO6341545A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Abstract

La presente invención se relaciona a un método para preparar una microesfera de liberación sostenida que puede controlar la liberación a largo plazo de un fármaco. Más particularmente, como la preparación de una microesfera en la cual un fármaco se carga en un portador que comprende un polímero biodegradable, la presente invención se relaciona a un método para preparar una microesfera de liberación sostenida en donde se utiliza un método de evaporación de intra-intercambio de solvente por medio de cosolvente para suprimir la liberación repentina inicial de la sustancia fisiológicamente activa, para liberar la sustancia fisiológicamente activa en el cuerpo continua y uniformemente.
CO11023782A 2008-08-29 2011-02-28 Metodo para elaborar una microesfera de liberacion sostenida mediante un metodo de la evaporacion de solvente CO6341545A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020080085368A KR101113044B1 (ko) 2008-08-29 2008-08-29 용매교류증발법에 의한 서방출성 미립구의 제조방법

Publications (1)

Publication Number Publication Date
CO6341545A2 true CO6341545A2 (es) 2011-11-21

Family

ID=41722136

Family Applications (1)

Application Number Title Priority Date Filing Date
CO11023782A CO6341545A2 (es) 2008-08-29 2011-02-28 Metodo para elaborar una microesfera de liberacion sostenida mediante un metodo de la evaporacion de solvente

Country Status (11)

Country Link
US (1) US20110200679A1 (es)
EP (1) EP2327397A2 (es)
JP (1) JP2012501321A (es)
KR (1) KR101113044B1 (es)
CN (1) CN102137657A (es)
BR (1) BRPI0917714A2 (es)
CL (1) CL2011000393A1 (es)
CO (1) CO6341545A2 (es)
MX (1) MX2011002210A (es)
RU (1) RU2011111714A (es)
WO (1) WO2010024615A2 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120011344A (ko) * 2010-07-21 2012-02-08 에스케이케미칼주식회사 고분자 미립구의 제조방법 및 그 방법에 의해 제조된 고분자 미립구
CN102755627B (zh) * 2012-01-31 2014-04-02 赛乐医药科技(上海)有限公司 一种戈舍瑞林缓释植入剂的制备方法
US9393211B2 (en) * 2013-03-15 2016-07-19 Oakwood Laboratories LLC High drug load buprenorphine microspheres and method of producing same
US9636308B2 (en) 2013-03-15 2017-05-02 Oakwood Laboratories LLC High drug load buprenorphine microspheres and method of producing same
PL2987484T3 (pl) * 2013-04-18 2019-07-31 Shandong Luye Pharmaceutical Co., Ltd. Kompozycja farmaceutyczna mikrosfery o przedłużonym uwalnianiu gosereliny
MX2016001607A (es) * 2013-08-06 2016-06-06 Dong Kook Pharm Co Ltd Microesferas de entecavir y composicion farmaceutica para administracion parenteral que contiene las mismas.
JP6238401B2 (ja) * 2013-10-28 2017-11-29 日本化薬株式会社 生理活性ペプチド徐放性微粒子及びその製造方法
KR101695440B1 (ko) * 2014-09-12 2017-01-11 주식회사 고려비엔피 불화퀴놀론계 항생제를 담지한 생분해성 고분자 미립구형 서방출 제제의 제조방법
KR101779846B1 (ko) 2015-08-31 2017-10-10 주식회사 티케이케미칼 나노다공성을 갖는 서방성 미분말과 그 제조방법
KR101961848B1 (ko) * 2016-08-25 2019-03-25 영진약품 주식회사 C18:1, c18:1(oh) 또는 c18:2의 장쇄 지방산이 포함된 오일류를 포함한 방출억제제를 적용한 서방출성 마이크로스피어 및 이의 제조방법
KR20190110567A (ko) * 2017-01-31 2019-09-30 베루 인코퍼레이티드 성선 자극 호르몬-방출 호르몬(GnRH) 길항제의 장기간 방출을 위한 조성물 및 방법
KR102142026B1 (ko) * 2017-05-31 2020-08-06 주식회사 대웅제약 방출제어가 용이한 서방성 약물 미립자의 제조방법
KR102047983B1 (ko) 2017-11-30 2019-11-22 주식회사 지투지바이오 안전성 및 저장 안정성이 향상된 생분해성 미립구의 제조방법
KR20190121699A (ko) * 2018-04-18 2019-10-28 (주)인벤티지랩 데옥시콜린산을 포함하는 피하 주사용 조성물 및 이의 제조 방법
WO2019203543A1 (ko) * 2018-04-18 2019-10-24 (주)인벤티지랩 데옥시콜린산을 포함하는 피하 주사용 조성물 및 이의 제조 방법
US20220023217A1 (en) * 2018-12-17 2022-01-27 G2Gbio, Inc. Sustained-release injection comprising deslorelin, and preparation method therefor
WO2023090899A1 (ko) * 2021-11-18 2023-05-25 (주)인벤티지랩 난용성 약물을 포함하는 마이크로 입자의 제조 방법
CN114668729B (zh) * 2022-02-25 2023-09-29 浙江圣兆药物科技股份有限公司 一种曲普瑞林缓释制剂的连续化生产方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366734A (en) 1981-02-16 1994-11-22 Zeneca Limited Continuous release pharmaceutical compositions
TW448055B (en) 1995-09-04 2001-08-01 Takeda Chemical Industries Ltd Method of production of sustained-release preparation
DE69738124T2 (de) * 1997-05-08 2008-06-12 Amarnath Maitra Verfahren zur Herstellung von hochmonodisperser, Polymeren, hydrophiler Nanopartikel
KR100754352B1 (ko) * 1999-05-24 2007-08-31 소너스파머슈티칼즈인코포레이티드 난용성 약물용 에멀젼 부형제의 제조방법
JP3523821B2 (ja) * 2000-02-09 2004-04-26 ナノキャリア株式会社 薬物が封入されたポリマーミセルの製造方法および該ポリマーミセル組成物
KR100433061B1 (ko) 2001-09-12 2004-05-28 김시환 휴대용 멀티 표시장치
CN101444476B (zh) * 2001-12-26 2011-11-30 武田药品工业株式会社 新微球和其生产方法
KR100709015B1 (ko) * 2002-11-13 2007-04-18 (주)아모레퍼시픽 지속적 약물방출이 가능한 고분자 미립구 및 그 제조방법
JP2007514529A (ja) * 2003-12-19 2007-06-07 エスセーエフ テクノロジーズ アクティーゼルスカブ 微粒子およびその他の物質を調製するためのシステム
TW200529890A (en) * 2004-02-10 2005-09-16 Takeda Pharmaceutical Sustained-release preparations
KR100816065B1 (ko) * 2006-11-27 2008-03-24 동국제약 주식회사 초기 방출억제 특성이 우수한 서방출성 마이크로캡슐의제조방법 및 이에 의해 제조되는 마이크로캡슐

Also Published As

Publication number Publication date
WO2010024615A2 (ko) 2010-03-04
JP2012501321A (ja) 2012-01-19
CN102137657A (zh) 2011-07-27
WO2010024615A3 (ko) 2010-06-17
BRPI0917714A2 (pt) 2016-02-16
KR101113044B1 (ko) 2012-02-27
RU2011111714A (ru) 2012-10-10
EP2327397A2 (en) 2011-06-01
KR20100026384A (ko) 2010-03-10
CL2011000393A1 (es) 2011-08-19
US20110200679A1 (en) 2011-08-18
MX2011002210A (es) 2011-06-24

Similar Documents

Publication Publication Date Title
CO6341545A2 (es) Metodo para elaborar una microesfera de liberacion sostenida mediante un metodo de la evaporacion de solvente
TR201902233T4 (tr) Hızlı çözünen katı dozaj formu.
BR112015019546A2 (pt) implante de distribuição de drogas prolongado
AR077325A1 (es) Diferenciacion de celulas madre embrionarias humanas
CY1117964T1 (el) Αντιψυχωτικη ενεσιμη συνθεση μακρας διαρκειας δρασης τεχνικος τομεας
MX2011004994A (es) Metodo para preparar microesferas y microesferas producidas por el mismo.
PE20071139A1 (es) Formulacion de liberacion sostenida que comprende octreotida y dos o mas polimeros de polilactido-co-glicolido
EA201190300A1 (ru) Микроэлектрод и множественные микроэлектроды, содержащие устройства для высвобождения лекарственных средств в ткани
AR063446A1 (es) Sistema de administracion para el tratamiento remoto de un animal
BR112012021256A2 (pt) composições para liberação alvejada de sirna.
AR075913A1 (es) Metodo para preparar un conjugado polipeptidico fisiologicamente activo de sitio especifico
EA201590583A1 (ru) Способ получения терапевтических наночастиц
BRPI0809326B8 (pt) métodos de preparação de microesfera de liberação controlada contendo exendina com camada de revestimento, composição e microesfera
AR027520A1 (es) Implantes farmaceuticos para liberar de manera controlable una droga y metodos para fabricar y administrar el implante
UY31816A (es) Agente para el tratamiento y/o prevención de una enfemedad autoinmune y para la formación de células t reguladoras
MX2009011275A (es) Una composicion de microesferas biodegradables adecuadas para la liberacion controlada de peptido de control de la glucosa y formulacion de la misma.
IN2012DN00570A (es)
UY31975A (es) Sistema y administración transdérmica de estrógeno
EP3494959A3 (en) Sustained release latanoprost implant
CL2012001725A1 (es) Procesos para la preparacion de 2-(6-fluoro-1h-indol-3-il)etanamina, a partir de (6-fluoro-1h-indol-3-il)acetonitrilo y un catalizador de metal de transicion en un solvente alcoholico, posteriormente hidrogenar la mezcla con h2.
ATE539676T1 (de) Vorrichtung zur verabreichung eines implantierbaren monitors
BRPI0910037A2 (pt) método para fabricar polilactídeo estável
CR20150299A (es) Dispersión sólida de un modulador selectivo de los receptores de progesterona
PE20110876A1 (es) Formulacion de deposito de octreotida con niveles de exposicion constantemente altos
CO6260054A2 (es) Extruidos con enmascaramiento del sabor mejorado

Legal Events

Date Code Title Description
FC Application refused